Haiying Xu

23.8k citations

49 papers · 8.1k indexed · 3 hit papers · h-index 32

Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers 22
- CAR-T cell therapy research 11
Immunology top 0.5%
- Immunotherapy and Immune Responses 22
- Immune Cell Function and Interaction 9
- T-cell and B-cell Immunology 4
Cancer Research top 2%
- Breast Cancer Treatment Studies 4
Pulmonary and Respiratory Medicine top 1%
Pathology and Forensic Medicine top 2%
Surgery
- Breast Implant and Reconstruction 7
Molecular Biology
- Single-cell and spatial transcriptomics 3

Co-authors: Janis M. Taube Lieping Chen Robert A. Anders Drew M. Pardoll Suzanne L. Topalian Julie R. Brahmer Jung Ho Kim Alison Klein
Cited by: Oncology Immunology Cancer Research
Partner nations: United States China Australia

In The Last Decade

Haiying Xu

49 papers receiving 8.0k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2015 Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancer
2014 Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy
2012 Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape

Peers

Countries citing papers authored by Haiying Xu

Since Specialization

Citations

This map shows the geographic impact of Haiying Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiying Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiying Xu more than expected).

Fields of papers citing papers by Haiying Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiying Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiying Xu. The network helps show where Haiying Xu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Haiying Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Haiying Xu Line = papers co-authored together Haiying Xu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Whole-Slide Imaging, Mutual Information Registration for Multiplex Immunohistochemistry and Immunofluorescence Joshua Doyle,Benjamin Green,Margaret Eminizer,Daniel Jiménez‐Sánchez,Steve Lu,Elizabeth L. Engle,Haiying Xu,Aleksandra Ogurtsova,Jonathan R. Lai,Sigfredo Soto-Diaz,J. Roskes,Julie S. Deutsch,Janis M. Taube,Joel Sunshine,Alexander S. Szalay	2023	4
2	CD30 Lateral Flow and Enzyme-Linked Immunosorbent Assays for Detection of BIA-ALCL: A Pilot Study Victoria G. Zeyl,Haiying Xu,Imran Khan,Jason T. Machan,Mark W. Clemens,Honghua Hu,Anand K. Deva,Caroline Glicksman,Patricia McGuire,William P. Adams,David A. Sieber,Mithun Sinha,Marshall E. Kadin	2023	1
3	Spatial UMAP and Image Cytometry for Topographic Immuno-oncology Biomarker Discovery Nicolás A. Giraldo,Sneha Berry,Étienne Becht,Deniz Ateş Özdemir,Kara M. Schenk,Elizabeth L. Engle,Benjamin Green,Peter Nguyen,Abha Soni,Julie E. Stein,Farah Succaria,Aleksandra Ogurtsova,Haiying Xu,Raphaël Gottardo,Robert A. Anders,Evan J. Lipson,Ludmila Danilova,Alexander S. Baras,Janis M. Taube	2021	6
4	PD-L1 expression in inflammatory myofibroblastic tumors Tricia R. Cottrell,Anh T Duong,Christopher D. Gocke,Haiying Xu,Aleksandra Ogurtsova,Janis M. Taube,Deborah Belchis	2018	16
5	PD-L1 Expression in Melanoma: A Quantitative Immunohistochemical Antibody Comparison Joel Sunshine,Peter Nguyen,Genevieve J. Kaunitz,Tricia R. Cottrell,Sneha Berry,Jessica Esandrio,Haiying Xu,Aleksandra Ogurtsova,Karen B. Bleich,Toby C. Cornish,Evan J. Lipson,Robert A. Anders,Janis M. Taube	2017	109
6	Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade Evan J. Lipson,Mohammed Lilo,Aleksandra Ogurtsova,Jessica Esandrio,Haiying Xu,Patricia Brothers,Megan D. Schollenberger,William H. Sharfman,Janis M. Taube	2017	115
7	PD-L1 expression and the immune microenvironment in primary invasive lobular carcinomas of the breast Elizabeth D. Thompson,Janis M. Taube,Rebecca J Asch-Kendrick,Aleksandra Ogurtsova,Haiying Xu,Rajni Sharma,Alan K. Meeker,Pedram Argani,Leisha A. Emens,Ashley Cimino‐Mathews	2017	36
8	Melanoma subtypes demonstrate distinct PD-L1 expression profiles Genevieve J. Kaunitz,Tricia R. Cottrell,Mohammed Lilo,Valliammai Muthappan,Jessica Esandrio,Sneha Berry,Haiying Xu,Aleksandra Ogurtsova,Robert A. Anders,Alexander H. Fischer,Stefan Kraft,Meg R. Gerstenblith,Cheryl L. Thompson,Kord Honda,Jonathan D. Cuda,Charles G. Eberhart,James T. Handa,Evan J. Lipson,Janis M. Taube	2017	157
9	The Intratumoral Balance between Metabolic and Immunologic Gene Expression Is Associated with Anti–PD-1 Response in Patients with Renal Cell Carcinoma Maria Libera Ascierto,Tracee L. McMiller,Alan E. Berger,Ludmila Danilova,Robert A. Anders,George J. Netto,Haiying Xu,Theresa S. Pritchard,Jinshui Fan,Chris Cheadle,Leslie Cope,Charles G. Drake,Drew M. Pardoll,Janis M. Taube,Suzanne L. Topalian	2016	133
10	Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma Marshall E. Kadin,Anand K. Deva,Haiying Xu,John Morgan,Pranay D. Khare,Roderick A.F. MacLeod,Bruce W. Van Natta,William P. Adams,Garry S. Brody,Alan L. Epstein	2016	115
11	Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancerbreakdown → Kristin J. Lastwika,Willie Wilson,Qing Kay Li,Jeffrey W. Norris,Haiying Xu,Sharon R. Ghazarian,Hiroshi Kitagawa,Shigeru Kawabata,Janis M. Taube,Sheng Yao,Linda N. Liu,Joell J. Gills,Phillip A. Dennis	2015	643
12	Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade Janis M. Taube,Geoffrey D. Young,Tracee L. McMiller,Shuming Chen,January T. Salas,Theresa S. Pritchard,Haiying Xu,Alan K. Meeker,Jinshui Fan,Chris Cheadle,Alan E. Berger,Drew M. Pardoll,Suzanne L. Topalian	2015	196
13	B7-H3 Promotes Pathogenesis of Autoimmune Disease and Inflammation by Regulating the Activity of Different T Cell Subsets Liqun Luo,Gefeng Zhu,Haiying Xu,Sheng Yao,Gang Zhou,Yuwen Zhu,Koji Tamada,Lanqing Huang,Andrew S. Flies,Megan Broadwater,William Ruff,Jan M. A. van Deursen,Ignacio Melero,Zhou Zhu,Lieping Chen	2015	96
14	PD-L1 Expression in Melanocytic Lesions Does Not Correlate with the BRAF V600E Mutation Nemanja Rodić,Robert A. Anders,James R. Eshleman,Ming-Tseh Lin,Haiying Xu,Jung Ho Kim,Katie Beierl,Shuming Chen,Brandon Luber,Hao Wang,Suzanne L. Topalian,Drew M. Pardoll,Janis M. Taube	2014	42
15	Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapybreakdown → Janis M. Taube,Alison Klein,Julie R. Brahmer,Haiying Xu,Xiaoyu Pan,Jung Ho Kim,Lieping Chen,Drew M. Pardoll,Suzanne L. Topalian,Robert A. Anders	2014	1873
16	PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment Dimitrios Mathios,Jacob Ruzevick,Christopher M. Jackson,Haiying Xu,Sagar Shah,Janis M. Taube,Peter C. Burger,Edward F. McCarthy,Alfredo Quiñones‐Hinojosa,Drew M. Pardoll,Michael Lim	2014	60
17	B7-H2 Is a Costimulatory Ligand for CD28 in Human Sheng Yao,Yuwen Zhu,Gefeng Zhu,Mathew M. Augustine,Linghua Zheng,Diana Goode,Megan Broadwater,William Ruff,Sarah J. Flies,Haiying Xu,Dallas B. Flies,Liqun Luo,Shengdian Wang,Lieping Chen	2011	118
18	Potential Role of Decoy B7-H4 in the Pathogenesis of Rheumatoid Arthritis: A Mouse Model Informed by Clinical Data Takeshi Azuma,Gefeng Zhu,Haiying Xu,A. Rietz,Charles G. Drake,Eric L. Matteson,Lieping Chen	2009	59
19	Leucocyte‐associated immunoglobulin‐like receptor‐1 is an inhibitory regulator of contact hypersensitivity Ryusuke Omiya,Fumihiko Tsushima,Hidehiko Narazaki,Yukimi Sakoda,Atsuo Kuramasu,Hyun Soo Kim,Haiying Xu,Hideto Tamura,Gefeng Zhu,Lieping Chen,Koji Tamada	2009	16
20	B7-H4–deficient mice display augmented neutrophil-mediated innate immunity Gefeng Zhu,Mathew M. Augustine,Takeshi Azuma,Liqun Luo,Sheng Yao,Sudarshan Anand,A. Rietz,Jiaqiang Huang,Haiying Xu,Andrew S. Flies,Sarah J. Flies,Koji Tamada,Marco Colonna,Jan M. A. van Deursen,Lieping Chen	2008	68

About Haiying Xu

Haiying Xu is a scholar working on Immunology, Oncology and Dermatology, having authored 49 papers that have together received 8.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (22 papers), Cancer Immunotherapy and Biomarkers (22 papers), CAR-T cell therapy research (11 papers), Immune Cell Function and Interaction (9 papers), Breast Implant and Reconstruction (7 papers), Breast Cancer Treatment Studies (4 papers), T-cell and B-cell Immunology (4 papers) and Single-cell and spatial transcriptomics (3 papers). The work is most often cited by research in Oncology (6.3k citations), Immunology (4.0k citations) and Cancer Research (786 citations). Haiying Xu has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Janis M. Taube, Lieping Chen, Robert A. Anders, Drew M. Pardoll, Suzanne L. Topalian, Julie R. Brahmer, Jung Ho Kim, Alison Klein, Xiaoyu Pan and Rajni Sharma.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact